NEW YORK (GenomeWeb News) – Integrated DNA Technologies today announced that it has created a new business unit called Clinical and Commercial Manufacturing, which will manufacture oligonucleotides for use in diagnostic products.
 
The firm also said that it has received ISO 13485:2003 certification at its facility in Coralville, Iowa, which houses the new unit.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.